Logo American Journal of Case Reports

Call: 1.631.629.4328
Mon-Fri 10 am - 2 pm EST

Contact Us

Logo American Journal of Case Reports Logo American Journal of Case Reports Logo American Journal of Case Reports

07 June 2021: Articles  Poland

The Multifactorial Pathogenesis of Calciphylaxis: A Case Report

Challenging differential diagnosis, Rare disease

Marta Turek1ABCDEFG*, Joanna Stępniewska1ADE, Jacek Różański1D

DOI: 10.12659/AJCR.930026

Am J Case Rep 2021; 22:e930026

0 Comments

Abstract

BACKGROUND: Calciphylaxis is a rare and lifethreatening syndrome characterized by small vascular calcifications, which lead to the occlusion of blood vessels and painful skin lesions with tissue necrosis. Although the disease can develop in a population without kidney failure, it is typically detected in patients receiving dialysis, with an increasing frequency ranging from 1% to 4%. Therefore, the disease is also known as calcific uremic arteriolopathy. The prognosis in patients with coexisting chronic kidney disease is very poor, with a 1-year mortality rate of up to 80%. Numerous risk factors for calciphylaxis have been described, such as obesity, diabetes mellitus, female sex, White race, overuse of calcium and vitamin D supplements, and vitamin K deficiency. The disease is often accompanied by disorders such as hyperphosphatemia, elevated parathyroid hormone level, and a deficiency of natural calcification inhibitors, such as fetuin-A and matrix Gla protein. However, not all patients with calciphylaxis have the abnormalities described above, suggesting that the pathogenesis of calciphylaxis is multifactorial and unfortunately still uncertain.

CASE REPORT: We report a case of calciphylaxis in a 52-year-old White woman with multiple comorbidities and on chronic hemodialysis treatment, who presented with severe subcutaneous painful nodules and necrotic ulcers on both legs.

CONCLUSIONS: Although the prognosis of this rare and underrecognized disease is poor, an early diagnosis and interdisciplinary treatment including pain relief, wound care, appropriate nutritional support, correction of mineral parameters, administration of sodium thiosulphate, and adequate hemodialysis therapy can improve patient quality of life.

Keywords: calciphylaxis, Renal Dialysis, renal insufficiency, Kidney Failure, Chronic, Quality of Life, vascular calcification

Background

Calciphylaxis is a rare and life-threatening syndrome characterized by small vascular calcifications, which lead to blood vessel occlusion and tissue necrosis [1]. The dominant clinical manifestation of this disorder involves painful skin lesions such as induration, nodules, purpura, and ulcers, but it can also involve other organs including the muscles, eye, or digestive tract and lead to dysfunction. The multiple bilateral nonhealing wounds appear on the extremities and are often secondary infections [2]. The wounds can cause a systemic inflammatory response, which can lead to sepsis and death in many patients [3]. In most cases, calciphylaxis affects patients who have advanced kidney failure and are being treated with renal replacement therapy, including hemodialysis and peritoneal dialysis, or have had kidney transplantation. However, the disease also occurs in individuals with adequate kidney function [4,5]. The other most common causes of calciphylaxis are cancer, chemotherapy, alcoholic liver disease, diabetes, POEMS syndrome, primary hyperparathyroidism, and connective tissue diseases [6]. The prognosis in patients with coexisting chronic kidney disease is very poor with a 1-year mortality rate of up to 80%, compared with that of patients without chronic kidney disease, which is up to 45%. Perhaps due to the complex and largely unknown pathogenesis of calciphylaxis, there have been no randomized controlled trials that have led to an approved therapy [7]. Therefore, an interdisciplinary approach is essential for the effective treatment of calciphylaxis [2].

Case Report

A 52-year-old White woman was admitted to the hospital for a calcium-phosphate imbalance and modification of therapy. The patient had a history of chronic kidney disease, for which she had been receiving hemodialysis treatment for 6 years, diabetes mellitus type 2, chronic atrial fibrillation treated with warfarin therapy, systemic lupus erythematosus, myasthenia gravis, obesity (body mass index, 32.5 kg/m2), and left knee arthroplasty. The patient reported having pain of the left lower extremity for 2 weeks prior to presentation. During the physical examination, palpable subcutaneous painful nodules were found in both legs (Figure 1), and the skin of the left leg had local signs of inflammation (redness, increased warmness). The left extremity was also pale and swollen. A peripheral pulse in this leg was not present, with a pulse palpable only on the femoral artery. The laboratory tests revealed normocytic, normochromic anemia, elevated C-reactive protein levels, parathormone levels, and plasma phosphorus concentration (Table 1). The Doppler ultrasound examination of the left leg showed numerous mid-tissue calcifications, features of superficial venous thrombosis, and critical stenosis of the left superficial femoral and popliteal artery due to atherosclerosis, which was confirmed by computer tomography angiography (Figure 2). The patient had a consultation with the vascular surgeon and was qualified for percutaneous transluminal angioplasty of the left popliteal artery. The day before the surgery, she presented with coffee-ground vomitus with deterioration of red cell parameters in the blood morphology. A gastroscopy was performed, but the localization of a bleeding source was not found. After the episode of gastrointestinal bleeding, the worsening of pain and gradual deterioration of the local left leg skin lesions were observed. A confluent blister and extensive ulceration covered with necrotic black eschar formed (Figure 3). The repeated laboratory tests revealed a significant increase in inflammatory parameters (Table 1). Owing to the overall clinical observation of the patient, we decided to perform a biopsy of a skin nodule, which showed extravascular soft tissue calcification and calcification of small vessels without angiitis. The patient was diagnosed with calciphylaxis. The initial treatment included administration of targeted antibiotics (piperacillin/tazobactam), cinacalcet, opioids, low-molecular-weight heparin (enoxaparin sodium), restoration of proper protein balance, discontinuation of calcium supplementation, intensification of hemodialysis treatment, and surgical debridement of the ulcers. Percutaneous transluminal angioplasty of the left popliteal artery was performed after the patient’s condition stabilized. During the intervention, 2 stents were implanted, and the blood flow was restored. As a result of the treatment, the pain, swelling, redness, and ulceration of the left extremity gradually decreased.

Discussion

The term “calciphylaxis” was first used in 1961 by Hans Selye to describe soft tissue calcification in rats caused experimentally by the administration of vitamin D, parathormone, and irritant factors such as calcium chloride [8]. The first case of calciphylaxis in a patient with end-stage chronic kidney disease was published by Bryant and White in 1898 [9]. Calciphylaxis is characterized by progressive necrotic skin lesions that lead to poorly healing ulcers. Initially, the skin lesions may resemble livedo reticularis or erythematous nodules, plaques, or blisters [10]. The involvement of the skin and subcutaneous tissue varies in intensity, and therefore the macroscopic picture includes a wide range of symptoms. As the lesion grows larger, it causes necrosis in the middle part of the lesion and ulceration [11]. In the present case, we observed such a gradual progression in skin and subcutaneous tissue changes. Surgical debridement was an important part of the management of the disease in our patient. The total duration of the illness was approximately 1 year and appeared after 6 years of hemodialysis treatment. The origin of chronic kidney disease in the present case was multifactorial. Most of our patient’s other conditions also posed a risk of calciphylaxis, such as lupus erythematosus, which had been treated with immunosuppressive drugs and corticosteroids in the past, diabetes mellitus, and obesity. No obvious trigger factor for calciphylaxis was found, but based on the animal model, the phosphorus-calcium imbalance with a high parathormone level and excessive doses of vitamin D might have provoked the manifestation of the disease. Therefore, the first-line treatment included the discontinuation of calcium and vitamin D supplements and intensification of dialysis therapy using a dialysate with a low calcium concentration. Parathyroidectomy or cinacalcet treatment are also established procedures for calciphylaxis. In our patient, the direct cause of the deterioration of skin lesions was an episode of gastrointestinal bleeding, most likely due to ischemia. The patient’s warfarin treatment also seemed to play an important role as a cause of calciphylaxis. The data in the literature have indicated that 50% of patients with chronic kidney disease and calciphylaxis were treated with warfarin, which increased mortality in this group. Early diagnosis is extremely important, but differential diagnosis is difficult because the list of other potential diagnoses is long and includes primary skin diseases as well as internal diseases with secondary skin manifestations [12]. Our patient was diagnosed with atherosclerosis of the lower extremities. The skin changes due to calciphylaxis needed to be differentiated from those due to chronic limb ischemia. The performed angioplasty with stent implantation resulted in the clinical improvement of pain and wound healing. The routine skin biopsy is not recommended because it often causes secondary deterioration of the local condition and can also contribute to infection [13], even though some authors consider it to be the criterion standard [14]. In calciphylaxis, histopathological examination reveals calcifications in the middle layer of the small and medium arteries, intimal fibrosis, and intravascular thrombus [15]. In the present patient, the biopsy of skin lesions enabled us to establish the final diagnosis. However, a simple X-ray of the affected area demonstrated the presence of calcifications of the medium and small vessels. Currently, there have been no randomized controlled trials that have led to an approved therapy for calciphylaxis [7]. The management is symptomatic and requires a multidisciplinary approach and comprehensive cooperation between an internist, nephrolo-gist, and surgeon. Management of calciphylaxis includes pain relief, wound care, appropriate nutritional support, antibiotic therapy in the case of infected wounds, correction of mineral parameters, hyperbaric oxygen therapy, local and systemic administration of sodium thiosulphate, and adequate hemodialysis therapy. It is also important to avoid and modify the risk factors [5].

Conclusions

Calciphylaxis is a rare disease, and making a diagnosis, especially in the early stages, is difficult. Initially, diagnosis should be guided by the clinical image. The purpose of this case report is to emphasize the need for considering calciphylaxis in the differential diagnosis of skin lesions such as induration, nodules, purpura, and ulcers, especially in patients with chronic kidney disease with additional risk factors. The predisposing conditions in our patient were female sex, White race, obesity, diabetes mellitus, warfarin therapy, hyperphosphatemia, hyperparathyroidism, and autoimmune disorders. Although the prognosis of this rare and underrecognized disease is poor, an early diagnosis and interdisciplinary treatment can improve a patient’s quality of life.

References:

1.. Salmhofer H, Franzen M, Hitzl W, Multi-modal treatment of calciphylaxis with sodium-thiosulfate, cinacalcet and sevelamer including long-term data: Kidney Blood Press Res, 2013; 37; 346-59

2.. Nigwekar SU, Thadhani R, Brandenburg VM, Calciphylaxis: N Engl J Med, 2018; 378; 1704-14

3.. Bhambri S, Bhambri A, Del Rosso JQ, Calciphylaxis: A review: J Clin Aesthet Dermatol, 2008; 1; 38-41

4.. Weenig RH, Sewell LD, Davis MDP, Calciphylaxis: Natural history, risk factor analysis, and outcome: J Am Acad Dermatol, 2007; 56(4); 569-79

5.. Nigwekar SU, Kroshinsky D, Nazarian RM, Calciphylaxis: Risk factors, diagnosis, and treatment: Am J Kidney Dis, 2015; 6; 133146

6.. Goel SK, Bellovich K, McCullough PA, Treatment of severe metastatic calcification and calciphylaxis in dialysis patients: Int J Nephrol, 2011; 2011; 701603

7.. Bryant JH, White WH, A case of calcification of the arteries and obliterative endarteritis, associated with hydronephrosis, in a child aged six months: Guys Hosp Rep, 1898; 55; 17-20

8.. Selye H, Gentile G, Jean P, An experimental model of “dermatomyositis” induced by calciphylaxis: Can Med Assoc J, 1961; 85(14); 770-76

9.. Nigwekar SU, Wolf M, Sterns RH, Hix JK, Calciphylaxis from nonuremic causes: A systematic review: Clin J Am Soc Nephrol, 2008; 3(4); 1139-43

10.. Khanna U, Dominguez A, Keller J, Update on calciphylaxis etiopatho-genesis, diagnosis, and management: Cutis, 2018; 102(6); 395-400

11.. Cohen GF, Vyas NS, Sodium thiosulfate in the treatment of calciphylaxis: J Clin Aesthet Dermatol, 2013; 6; 41-44

12.. Brandenburg VM, Cozzolino M, Ketteler M, Calciphylaxis: A still unmet challenge: J Nephrol, 2011; 24(2); 142-48

13.. Kumar VA, Calcific uremic arteriolopathy: An underrecognized entity: Perm J, 2011; 15; 85-87

14.. Tindni A, Gaurav K, Panda M, Non-healing painful ulcers in a patient with chronic kidney disease and role of sodium thiosulfate: Case report: Cases J, 2008; 1; 178

15.. Sowers KM, Hayden MR, Calcific uremic arteriolopathy: Pathophysiology, reactive oxygen species and therapeutic approaches: Oxid Med Cell Longev, 2010; 3(2); 109-21

In Press

Case report  China

Effective Acupuncture in Treating Decade-Long Occipital Neuralgia in an Elderly Patient

Am J Case Rep In Press; DOI: 10.12659/AJCR.945546  

Case report  United Kingdom

Necrobiotic Pulmonary Nodules in Ulcerative Colitis: A Rare Case Report

Am J Case Rep In Press; DOI: 10.12659/AJCR.944005  

Case report  USA

Acute Heart Failure and Complete Heart Block in a Patient with Recurrent Diffuse Large B-Cell Lymphoma: A C...

Am J Case Rep In Press; DOI: 10.12659/AJCR.945085  

Case report  Indonesia

Successful Triple Flap Procedure for Thumb Reconstruction in Severe Hand Crush Injury

Am J Case Rep In Press; DOI: 10.12659/AJCR.945759  

Most Viewed Current Articles

21 Jun 2024 : Case report  China (mainland) 77,537

Intracranial Parasitic Fetus in a Living Infant: A Case Study with Surgical Intervention and Prognosis Anal...

DOI :10.12659/AJCR.944371

Am J Case Rep 2024; 25:e944371

0:00

07 Mar 2024 : Case report  USA 45,852

Neurocysticercosis Presenting as Migraine in the United States

DOI :10.12659/AJCR.943133

Am J Case Rep 2024; 25:e943133

0:00

10 Jan 2022 : Case report  Germany 32,861

A Report on the First 7 Sequential Patients Treated Within the C-Reactive Protein Apheresis in COVID (CACOV...

DOI :10.12659/AJCR.935263

Am J Case Rep 2022; 23:e935263

23 Feb 2022 : Case report  USA 21,213

Penile Necrosis Associated with Local Intravenous Injection of Cocaine

DOI :10.12659/AJCR.935250

Am J Case Rep 2022; 23:e935250

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

American Journal of Case Reports eISSN: 1941-5923
American Journal of Case Reports eISSN: 1941-5923